Press release content from Business Wire. The AP news staff was not involved in its creation.
Regis Expands Facilities to Support Rising Demand for U.S.-Based Custom API Pharmaceutical Development and Manufacturing
February 17, 2021 GMT
Siead Zegar, Director of Process Chemistry at Regis Technologies, in the company’s 9,000-square-foot expansion of its custom API development laboratories in Morton Grove, IL. (Photo: Business Wire)
Siead Zegar, Director of Process Chemistry at Regis Technologies, in the company’s 9,000-square-foot expansion of its custom API development laboratories in Morton Grove, IL. (Photo: Business Wire)
MORTON GROVE, Ill.--(BUSINESS WIRE)--Feb 17, 2021--
Regis Technologies, Inc. today announced the completion of a major expansion of their laboratory facilities for the development of active pharmaceutical ingredients (APIs) located in Morton Grove, Illinois. The expansion, which doubles the company’s capacity to take on new development projects, is now fully operational. It increases capabilities across Regis’ custom pharmaceutical service offerings, including analytical development, process chemistry, solid state chemistry, validation, stability studies, and commercialization.